ArticleBMC public health2026
Trends and determinants of pneumococcal vaccine uptake among U.S. adults, 2019-2024: a pooled cross-sectional analysis.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPneumococcal disease causes substantial morbidity and mortality among U.S. adults, with an estimated 20,000 deaths and 150,000 hospitalizations annually. Despite effective vaccines, coverage has remained below national targets. Pandemic-related disruptions and the 2022 Advisory Committee on Immunization Practices transition to simplified 15/20 valent Pneumococcal Conjugate Vaccine recommendations may have influenced uptake, but their impact has not been fully assessed. To address this gap, this study examines trends and determinants of pneumococcal vaccine uptake among U.S. adults following the pandemic and 2022 guideline changes.
methodsWe conducted a pooled cross-sectional analysis of National Health Interview Survey data from 2019 to 2024, including 166,948 adults aged ≥ 18 years with complete data. Weighted bivariate analyses assessed associations between vaccination uptake and demographic (age, sex, race/ethnicity), socioeconomic (education, income, citizenship), health-related (chronic conditions including Chronic Obstructive Pulmonary Disease, diabetes, asthma, and cancer; smoking; influenza vaccination), and healthcare access factors (insurance, usual source of care, recent provider visit). Multivariable logistic regression identified independent predictors of vaccination. All analyses incorporated National Health Interview Survey complex survey design and sampling weights.
resultsOverall weighted pneumococcal vaccination coverage remained low, fluctuating between 29.6% and 33.2% across survey years. Coverage was highest among adults aged ≥ 65 years (65.7%) but remained substantially below the Healthy People 2020 goal of 90%. Only 23.0% of adults aged 55-64 years reported vaccination despite risk-based recommendations. Disparities persisted across racial/ethnic groups, with Hispanic adults showing the lowest uptake (13.9%) compared to non-Hispanic White adults (29.1%). In adjusted analyses, age ≥ 65 years (odds ratio [OR] = 9.39; 95% confidence interval [CI]: 8.84-9.96), chronic conditions including Chronic Obstructive Pulmonary Disease (OR = 2.04; 95% CI: 1.90-2.20) and diabetes (OR = 1.84; 95% CI: 1.74-1.95), recent healthcare visits (OR = 1.41; 95% CI: 1.31-1.51), and influenza vaccination were strong independent predictors of uptake. Lack of insurance (OR = 0.89; 95% CI: 0.81-0.98), absence of a usual source of care (OR = 0.81; 95% CI: 0.74-0.88), and non-receipt of influenza vaccine (OR = 0.29; 95% CI: 0.28-0.30) were associated with lower odds of vaccination.
conclusionsPneumococcal vaccination coverage among U.S. adults remained stagnant from 2019 to 2024, with persistent gaps among younger high-risk adults and racial/ethnic minorities. Healthcare engagement, insurance, provider contact, and influenza vaccination, were strongly associated with uptake. These findings suggest that risk-based screening, provider recommendations, and improved access for underserved populations may help address coverage gaps.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.